The Authority/Pharmacotherapy Care model: an explanatory model of the drug use process in primary care{star, open}

Research in Social and Administrative Pharmacy

Volumn 1, Issue 1, 2005, Pages 101-117

  Einarson, Thomas R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Drug evaluation review; Drug use studies; Drug utilization; Drug utilization review; Model; Primary care

Indexed keywords

ARTICLE; DOCTOR PATIENT RELATION; DRUG THERAPY; DRUG UTILIZATION; HUMAN; PHYSICIAN ATTITUDE; PRIMARY HEALTH CARE; THEORETICAL MODEL;

DRUG THERAPY; DRUG UTILIZATION; HUMANS; MODELS, THEORETICAL; PHYSICIAN'S ROLE; PHYSICIAN-PATIENT RELATIONS; PRIMARY HEALTH CARE;

EID: 33745955745     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2004.12.003     Document Type: Article

References (55)

1. Brodie D.C., and Smith W.E. Constructing a conceptual model of drug utilization review. Hospitals 50 (1976) 143-144 146, 148 passim
2. Brodie D.C. Drug utilization review-planning. Hospitals 46 (1972) 103-112
3. Crooks J. Methods of "audit" in drug use. In: Duchene-Marullaz P. (Ed). Advances in Pharmacology and Therapeutics. Proceedings of the Seventh International Congress of Pharmacology, Paris 1978 (1979), Pergamon Press, Oxford 189-195
4. Brodie D.C., Smith Jr. W.E., and Hlynka J.N. Model for drug usage review in a hospital. Am J Hosp Pharm 34 (1977) 251-254
5. Brodie D.C., Lofholm P., and Benson R.A. A model for drug use review in a skilled nursing facility. J Am Pharm Assoc 17 (1977) 617-620 623
6. Stolar M.H. Model for a formal, prospective antibiotic use review program. Am J Hosp Pharm 35 (1978) 809-811
7. Pierpaoli P.G., Coarse J.F., and Tilton R.C. Antibiotic use control-an institutional model. Drug Intell Clin Pharm 10 (1976) 258-267
8. Rosman A.W., and Sawyer W.T. Population-based drug use evaluation. Top Hosp Pharm Manage 8 (1988) 76-92
9. Lunde P.K. Drug consumption surveys-a model for the analysis of health service?. Tidsskr Nor Laegeforen 98 (1978) 1544-1545
10. Chan K.W., Walker A.M., and Yood R.A. An equilibrium model of drug utilization. J Clin Epidemiol 46 (1993) 113-121
11. Donabedian A. The quality of care: how can it be assessed?. JAMA 260 (1988) 1743-1748
12. Titkow A. Illness behaviour and action: the patient role. Soc Sci Med 17 (1983) 637-646
13. Levine S., and Kozloff M.A. The sick role: assessment and overview. Ann Rev Sociol 4 (1978) 317-343
14. Bajcar J, Kenny N, Einarson TR. Patient care role of a consulting primary care pharmacist in a family physician office setting: an explanatory model. Res Soc Adm Pharm; submitted for publication.
15. Paylor N.R. The patient as caregiver. J Pastoral Care 38 (1984) 91-97
16. Bodenheimer T., Lorig K., Holman H., and Grumbach K. Patient self-management in primary care. JAMA 288 (2002) 2469-2475
17. Kessler R.C., Berglund P., Demier O., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 (2003) 3095-3105
18. Lawton J. Lay experiences of health and illness: past research and future agendas. Sociol Health Illn 25 (2003) 23-40
19. Sempere-Selva T., Peiro S., Sendra-Pina P., Martinez-Espin C., and Lopez-Aguilera I. Inappropriate use of an accident and emergency department: magnitude, associated factors, and reasons-an approach with explicit criteria. Ann Emerg Med 37 (2001) 568-579
20. Wagner P.J., and Hendrich J.E. Physician views on frequent medical use: patient beliefs and demographic and diagnostic correlates. J Fam Pract 36 (1993) 417-422
21. Andrade S.E., Gurwitz J.H., and Fish L.S. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists. Med Care 37 (1999) 424-430
22. Wilson K., and Rosenberg M.W. Accessibility and the Canadian health care system: squaring perceptions and realities. Health Policy 67 (2004) 137-148
23. Anderson M., and Rosenberg M.W. Ontario's underserviced area program revisited: an indirect analysis. Soc Sci Med 30 (1990) 35-44
24. Christiansen T., Pedersen K.M., Harvald B., Rasmussen K., Jorgensen J., and Svarer C. An investigation of the effect of regional variation in the treatment of hypertension. Soc Sci Med 28 (1989) 131-139
25. Ferguson R.I., and Maling T.J. The Nelson general practice prescribing project. Part I: a pilot audit of the regional prescribing profile. N Z Med 103 (1990) 558-560
26. Davis P., and Gribben B. Rational prescribing and interpractitioner variation. a multilevel approach. Int J Technol Assess Health Care 11 (1995) 428-442
27. Melander E., Bjorgell A., Bjorgell P., Ovhed I., and Molstad S. Medical audit changes physicians' prescribing of antibiotics for respiratory tract infections. Scand J Prim Health Care 17 (1999) 180-184
28. Gonzales R., Barrett Jr. P.H., Crane L.A., and Steiner J.F. Factors associated with antibiotic use for acute bronchitis. J Gen Intern Med 13 (1998) 541-548
29. Denig P., Haaijer-Ruskamp F.M., Wesseling H., and Versluis A. Towards understanding treatment preferences of hospital physicians. Soc Sci Med 36 (1993) 915-924
30. Chinburapa V., Larson L.N., Brucks M., Draugalis J., Bootman J.L., and Puto C.P. Physician prescribing decisions: the effects of situational involvement and task complexity on information acquisition and decision making. Soc Sci Med 36 (1993) 1473-1482
31. Sleath B., and Shih Y.C. Sociological influences on antidepressant prescribing. Soc Sci Med 56 (2003) 1335-1344
32. Sorensen T.D., and Biebighauser S.M. Pharmaceutical care leadership: an innovative pharmacy practice residency model. J Am Pharm Assoc 43 (2003) 527-532
33. Pilnick A. "Patient counselling" by pharmacists: four approaches to the delivery of counselling sequences and their interactional reception. Soc Sci Med 56 (2003) 835-849
34. Sturgess I.K., McElnay J.C., Hughes C.M., and Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci 25 (2003) 218-226
35. Prosser L.A., Ray G.T., O'Brien M., et al. Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine. Pediatrics 113 (2004) 283-290
36. Stuart B., and Grana J. Ability to pay and the decision to medicate. Med Care 36 (1998) 202-211
37. Furler M.D., Rolnick M.S., Lawday K.S., Mak M.W., and Einarson T.R. Cost impact of switching histamine(2)-receptor antagonists to nonprescription status. Ann Pharmacother 36 (2002) 1135-1141
38. Venturini F., Nichol M.B., Sung J.C., Bailey K.L., Cody M., and McCombs J.S. Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother 33 (1999) 281-288
39. Iskedjian M., Einarson T.R., MacKeigan L.D., et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther 24 (2002) 302-316
40. Kuzujanakis M., Kleinman K., Rifas-Shiman S., and Finkelstein J.A. Correlates of parental antibiotic knowledge, demand, and reported use. Ambul Pediatr 3 (2003) 203-210
41. Shalansky S.J., and Levy A.R. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother 36 (2002) 1532-1539
42. Einarson T.R., Metge C.J., Iskedjian M., and Mukherjee J. An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme A reductase inhibitors on health care utilization: a Canadian population-based study. Clin Ther 24 (2002) 2126-2136
43. Iskedjian M., and Einarson T.R. Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease. Pharmacoeconomics 21 (2003) 115-127
44. Hazra A., Tripathi S.K., and Alam M.S. Prescribing and dispensing activities at the health facilities of a non-governmental organization. Natl Med J India 13 (2000) 177-182
45. Morgan D.J., Sutters C.A., and Pugh S. Medical audit and formulary management: a policy for rational use of thrombolytic drugs. Postgrad Med J 67 (1991) 165-169
46. Sylvia L.M. A departmental model for drug-usage evaluation. Top Hosp Pharm Manage 11 (1991) 46-52
47. Sharp W.T., Driver P., and Bartlome P. Drug-usage evaluation: a system for the prospective evaluation of antibiotic utilization in minimum inhibitory concentration documented infections. Top Hosp Pharm Manage 11 (1991) 59-69
48. Brown N.J., Griffin M.R., Ray W.A., et al. A model for improving medication use in home health care patients. J Am Pharm Assoc 38 (1998) 696-702
49. Petitta A., Kaatz S., Estrada C., Effendi A., and Anandan J.V. The transition to medication system performance indicators. Top Hosp Pharm Manage 14 (1995) 20-26
50. Bunting Jr. R.F. A model drug usage evaluation program. J Qual Assur 12 (1990) 30-33 50
51. Lovejoy A.E., and Savage I. Prescribing analysis and cost tabulation (PACT) data: an introduction. Br J Community Nurs 6 (2001) 62-67
52. Kennie N.R., Schuster B.G., and Einarson T.R. Critical analysis of the pharmaceutical care research literature. Ann Pharmacother 32 (1998) 17-26
53. Carter B.L., Malone D.C., Billups S.J., et al. Interpreting the findings of the IMPROVE study. Am J Health Syst Pharm 58 (2001) 1330-1337
54. Ellis S.L., Carter B.L., Malone D.C., et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 20 (2000) 1508-1516
55. Baldwin R.C., Anderson D., Black S., et al. Faculty of Old Age Psychiatry Working Group, Royal College of Psychiatrists. Guideline for the management of late-life depression in primary care. Int J Geriatr Psychiatry 18 (2003) 829-838